Solasia Pharma KK (4597) Stock Price & News

Why is 4597 down 4.17%?

Dive Deeper

4597:TYO

Solasia Pharma KK

¥23.00

-4.17%

(-1.00) 1D

Nov 6, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4597...

Open

¥23

High

¥24

Low

¥22

Mkt. cap

6.29B

Avg. vol.

80.15M

Volume

88.60M

52-wk high

¥42

52-wk low

¥21

EPS

-¥3

Shares outstanding

104.68M

No. of employees

Open

¥23

High

¥24

Low

¥22

Mkt. cap

6.29B

Avg. vol.

80.15M

Volume

88.60M

52-wk high

¥42

52-wk low

¥21

EPS

-¥3

Shares outstanding

104.68M

No. of employees

Related stocks

4564

OncoTherapy Science, Inc.

News stories

From web sources and news partners

bloomingbit

16 minutes ago

Wall Street Turns Mixed; Nasdaq Gains 1.33%

Devdiscourse

14 minutes ago

US STOCKS-Nasdaq rebounds but remains on track for fourth straight weekly decline

TradingView

2 hours ago

Chip Stocks Are Now Cheaper Than the S&P 500 — Something Unseen During the Entire AI Boom

The Motley Fool

20 minutes ago

After the Midterm Rally, the Dow Is on Track to Beat the Nasdaq for the First Time Since 2022. Here's What History Says Could Come Next.

About Solasia Pharma KK

CEOYoshihiro Arai

Employees22

Founded2006

Headquarters-

SectorHealth Care

IndustryBiotechnology

Websitesolasia.co.jp

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	42.00M	338.00M	6.00M	2.00M
Cost of goods sold	1.00M	191.00M	1.00M	-
Cost of revenue	1.00M	191.00M	1.00M	-
Research and development expenses	82.00M	116.00M	112.00M	118.00M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	134.00M	178.00M	198.00M	149.00M
Operating expense	216.00M	294.00M	310.00M	267.00M
Total operating expenses	217.00M	485.00M	311.00M	267.00M
Operating income	-175.00M	-147.00M	-305.00M	-265.00M
Other non operating income	-3.00M	-1.00M	1.00M	-1.00M
EBT including unusual items	-171.00M	-150.00M	-307.00M	-272.00M
EBT excluding unusual items	-171.00M	-150.00M	-307.00M	-272.00M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-171.00M	-150.00M	-307.00M	-272.00M
Net profit margin	-407.14%	-44.38%	-5,116.67%	-13,600.00%
Earnings per share	-	-	-	-
Interest and investment income	7.00M	-	1.00M	-
Interest expense	-	-1.00M	-4.00M	-6.00M
Net interest expenses	7.00M	-1.00M	-3.00M	-6.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	-165.00M	-138.00M	-296.00M	-256.00M
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything